in which the subject is identified as having prostate carcinoma when the ratio of the signal intensity of fucose-unbound glycan to the signal intensity of fucose-bound glycan in the labeled PSA derivative is greater than 1.0, and identified as having benign prostatic hyperplasia when the ratio is...
International radiological bodies have agreed on a standard for how doctors evaluate MRI to confirm a diagnosis of prostate cancer. This promises to reduce the number of over diagnosis of insignificant cancers by to up to 89%. The new procedure also allows radiologists to identify up to 13% mor...
Prostate cancer management - Helping your patient choose what is best for him The biggest problems in prostate cancer management are how to identify patients with potentially life-threatening cancer, and how to choose the best form o... CF Heyns,AVD Merwe - 《Official Journal of the South Afri...
56、erent meaning from“Calcium-regulated transcription”In “To identify biomarkers of prostate cancer, we performed microarray analysis, using custom cDNA arrays”The second comma should be deleted AmbiguityEnsure correct use of “which”, commas and hyphensIn “Data were normalised to the internal ...
Problems with prostate tend to develop in men who are older than 50 years, which is why in this period of their life they should start visiting their urologists regularly. It is important to identify the symptoms at the initial stages, because the treatment is much easier and requires less ...
How_to_Write_a_World_Class_Paper ScientificandMedicalEditingandWriting HOWTOWRITEAWORLDCLASSPAPER TIPS,TRAPSANDTRAVESTIES 撰稿人DanielMcGowan,PhD理文编辑学术总监 提纲 •出版还是出局…•写出高质量的文章•准备•组织结构•语言•技术资料•根据审稿意见改写稿件并回复审稿意见 •论文发表道德规范 •...
presented findings on an AI-derived digital pathology-based biomarker for localized prostate cancer. Spratt and his colleagues digitized tumour biopsy slides from patients with localized cancer. Then they used the clinical and imaging data to train multimodal deep-learning AI to identify features that ...
In prostate cancer, patients with five or more CTCs at treatment start had significantly shorter median survival compared to those with no detectable CTCs. SHOW MORE An expert explained how circulating tumor cell count can identify possible clinical trial participants.This...
In this study, the researchers compared single drugs to each other, but the device could also be used to test different drug combinations by putting two or three drugs into the same reservoir, Jonas says. "This device could help us identify the best chemotherapy agents and combinations for eve...
how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny Michael V Zaragoza*,1,2, Martin C Brandon1, Marta Diegoli3, Eloisa Arbustini3 and Douglas C Wallace*,1,4 Pathogenic mitochondrial DNA (mtDNA) mutations leading to mitochondrial dysfunction can ca...